Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Understanding when points offer greater value than cash back can enhance your credit card strategy. Discover these key moments.
28,161 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
In 1973, Warren Buffett bought distressed Berkshire stock for $40 a share. The move epitomized his patient, crisis-dr...
Geopolitical tensions drive a risk-off market response as oil climbs and equities retreat, with investors weighing un...
Boeing enters 2026 with renewed momentum as travel demand rebounds and defense contracts grow. Here is the boeing sto...
Bitmine’s Ethereum hoard surges to 5.28 million ETH, placing the treasury near a 5% stake of total supply as the comp...
PepsiCo beat expectations in Q1 with revenue rising 8.5% and earnings surpassing estimates. International momentum an...
A Solana-based DEX reports a $1.34 million loss tied to five legacy pools. The attacker used forged LP tokens, and fu...
BlackRock has filed Form 8-A for a yield-bearing Bitcoin ETF, signaling a near-term launch window. Market commentary ...
Investors aiming to replace a $60,000 salary with monthly dividend ETFs face a simple math problem: how much capital ...
SBI Holdings, Ripple’s biggest shareholder outside the United States, is quietly developing institutional XRP lending...
The bond market is sending a sharp signal to Washington: rising deficits and policy gridlock could raise borrowing co...
Investors and households are bracing for the Federal Reserve's policy decision, with potential moves on borrowing cos...